Terence Friedlander, MD | Authors


The Future of Neoadjuvant Immunotherapy in MIBC

December 20, 2022

Dr Terence Friedlander closes his discussion by highlighting ongoing clinicals in neoadjuvant MIBC treatment that excite him and speculates on how he would use immunotherapy in patients with MIBC if it were available for use in both the neoadjuvant and adjuvant setting.